Peregrine Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-125,752
Closed -$8.67M 343
2024
Q1
$8.67M Sell
125,752
-43,877
-26% -$2.96M 0.25% 110
2023
Q4
$10.6M Sell
169,629
-29,234
-15% -$1.64M 0.32% 67
2023
Q3
$11.2M Sell
198,863
-36,110
-15% -$2.03M 0.33% 77
2023
Q2
$11.9M Buy
234,973
+434
+0.2% +$23.1K 0.32% 84
2023
Q1
$12.8M Buy
234,539
+27,456
+13% +$1.6M 0.37% 70
2022
Q4
$12.9M Buy
207,083
+23,393
+13% +$1.55M 0.41% 62
2022
Q3
$12.9M Sell
183,690
-55,272
-23% -$3.81M 0.42% 58
2022
Q2
$13.5M Sell
238,962
-1,586
-0.7% -$87K 0.41% 66
2022
Q1
$15.1M Sell
240,548
-77,161
-24% -$4.16M 0.36% 76
2021
Q4
$17.8M Buy
317,709
+22,220
+8% +$1.36M 0.36% 69
2021
Q3
$19.2M Sell
295,489
-97,189
-25% -$6.63M 0.4% 51
2021
Q2
$24.9M Sell
392,678
-20,949
-5% -$1.24M 0.45% 47
2021
Q1
$24.8M Sell
413,627
-57,728
-12% -$3.14M 0.46% 49
2020
Q4
$23.5M Sell
471,355
-48,538
-9% -$2.28M 0.45% 60
2020
Q3
$26.5M Sell
519,893
-49,602
-9% -$2.07M 0.7% 35
2020
Q2
$20M Sell
569,495
-2,836
-0.5% -$97.7K 0.57% 58
2020
Q1
$14.5M Sell
572,331
-41,190
-7% -$1.22M 0.52% 68
2019
Q4
$17M Buy
+613,521
New +$14.6M 0.43% 101

Other funds holding AXNX

Peregrine Capital Management's AXNX Position: Q2 2024 in Review

Peregrine Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 125,752 shares — an estimated $8.67M sold.

Peregrine Capital Management first reported a position in AXNX in Q4 2019 and held it in 18 quarters. The position peaked at $26.5M in Q3 2020. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Peregrine Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Peregrine Capital Management sold 125,752 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $8.67M.
  • Peregrine Capital Management first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 18 quarters.
  • Peregrine Capital Management's Axonics, Inc. Common Stock position peaked at $26.5M in Q3 2020.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Peregrine Capital Management's 13F filing for Q2 2024, filed 29 Jul 2024.